107. 若年性特発性関節炎 Juvenile idiopathic arthritis Clinical trials / Disease details

臨床試験数 : 441 / 薬物数 : 282 - (DrugBank : 56) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 142

16 trials found

diseases per page:

Showing 1 to 10 of 16 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-004284-30-DE (EUCTR)	13/02/2020	29/07/2019	Repsonse to Treatment with Canakinumab without steroids early after diagnosis of systemic onset juve ...	Effectiveness of Canakinumab for first line steroid free treatment in systemic onset juvenile idiopa ...	systemic juvenile idiopathic arthritis MedDRA version: 20.0;Level: LLT;Classification code 10079454; ...	Trade Name: Ilaris Product Name: Ilaris	Asklepios Klink Sankt Augustin	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 4	Germany
2	EUCTR2013-004867-29-ES (EUCTR)	20/10/2014	06/08/2014	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line use of Canakinumab	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and SafetywIth FIrst-line use of CanakinumabAn op ...	Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis(SJIA) MedDRA version: 17.0; ...	Trade Name: Ilaris Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	Novartis Farmacéutica, S.A.	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3;Phase 4	United States;Hong Kong;Spain;Turkey;Austria;Russian Federation;Israel;Italy;France;Hungary;Mexico;C ...
3	EUCTR2014-002872-95-FR (EUCTR)	15/09/2014	18/06/2015	A French extension study of canakinumab in patients with Systemic Juvenile Idiopathic Arthritis who ...	A French open-label extension study of canakinumab in patients with Systemic Juvenile Idiopathic Art ...	Systemic Juvenile Idiopathic Arthritis (SJIA) with active systemic manifestations MedDRA version: 18 ...	Trade Name: ILARIS Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	Novartis Pharma S.A.S	NULL	Not Recruiting			Female: yes Male: yes	15	Phase 4	France
4	EUCTR2012-003054-92-CZ (EUCTR)	18/04/2013	18/12/2012	A study to check how safe, beneficial and tolerable the drug canakinumab is for patients with system ...	An open-label, multi-arm, non-comparative safety and tolerability study of canakinumab (ACZ885) in p ...	Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis (SJIA) MedDRA version: 14.1 ...	Trade Name: ILARIS Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	220		United States;Greece;Spain;Turkey;Austria;Russian Federation;Israel;United Kingdom;Switzerland;Italy ...
5	EUCTR2012-003054-92-ES (EUCTR)	28/01/2013	21/12/2012	A study to check how safe, beneficial and tolerable the drug canakinumab is for patients with system ...	An open-label, multi-arm, non-comparative safety and tolerability study of canakinumab (ACZ885) in p ...	Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis (SJIA) MedDRA version: 14.1 ...	Trade Name: ILARIS Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	Novartis Farmaceutica, S.A.	NULL	Not Recruiting			Female: yes Male: yes	220		United States;Greece;Spain;Turkey;Austria;Israel;Russian Federation;Italy;Switzerland;United Kingdom ...
6	EUCTR2012-003054-92-AT (EUCTR)	24/01/2013	11/12/2012	A study to check how safe, beneficial and tolerable the drug canakinumab is for patients with system ...	An open-label, multi-arm, non-comparative safety and tolerability study of canakinumab (ACZ885) in p ...	Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis (SJIA) MedDRA version: 14.1 ...	Trade Name: ILARIS Product Name: Ilaris Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB Trade Name ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	239		United States;Greece;Spain;Turkey;Austria;Russian Federation;Israel;United Kingdom;Switzerland;Italy ...
7	EUCTR2008-008008-42-AT (EUCTR)	28/01/2010	30/12/2009	An open-label extension study of canakinumab (ACZ885) in patients with Systemic Juvenile Idiopathic ...	An open-label extension study of canakinumab (ACZ885) in patients with Systemic Juvenile Idiopathic ...	Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis (SJIA) MedDRA version: 14.1 ...	Trade Name: ILARIS Product Name: Canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB INN o ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	304		United States;Greece;Spain;Turkey;Austria;Israel;Russian Federation;Italy;Switzerland;United Kingdom ...
8	EUCTR2008-008008-42-NL (EUCTR)	05/11/2009	25/05/2009	research with children with severe reuma	An open-label extension study of canakinumab (ACZ885) in patients with Systemic Juvenile Idiopathic ...	Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis (SJIA) MedDRA version: 16.0 ...	Trade Name: ILARIS Product Name: Canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB INN o ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	210		United States;Greece;Spain;Turkey;Austria;Israel;Russian Federation;Italy;Switzerland;United Kingdom ...
9	EUCTR2008-005479-82-IT (EUCTR)	20/07/2009	05/08/2009		A randomized, double-blind, placebo controlled, withdrawal study of flare prevention of canakinumab ...	Systemic Juvenile Idiopathic Arthritis (SJIA) MedDRA version: 12.0;Level: LLT;Classification code 10 ...	Product Name: Canakinumab Product Code: ACZ885 INN or Proposed INN: ILARIS	NOVARTIS FARMA	NULL	Not Recruiting			Female: yes Male: yes	214		Hungary;United Kingdom;Germany;Denmark;Belgium;France;Spain;Italy;Greece;Austria;Sweden
10	EUCTR2008-005476-27-IT (EUCTR)	22/06/2009	05/08/2009	A randomized, double-blind, placebo controlled, singledose study to assess the initial efficacy of c ...	A randomized, double-blind, placebo controlled, singledose study to assess the initial efficacy of c ...	Systemic Juvenile Idiopathic Arthritis (SJIA) MedDRA version: 12.0;Level: LLT;Classification code 10 ...	Product Name: canakinumab Product Code: ACZ885G INN or Proposed INN: ILARIS	NOVARTIS FARMA	NULL	Not Recruiting			Female: yes Male: yes	122		Hungary;United Kingdom;Germany;Denmark;Belgium;France;Spain;Italy;Greece;Sweden

First Previous1 2Next Last